Cargando…
Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia
BACKGROUND: Prophylaxis with clotting factor replacement products is recommended by the Medical and Scientific Advisory Council of the National Hemophilia Foundation as the optimal therapy for the prevention of bleeding episodes in individuals with severe hemophilia A or B (< 1 IU per dL endogeno...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397835/ https://www.ncbi.nlm.nih.gov/pubmed/29952709 http://dx.doi.org/10.18553/jmcp.2018.24.7.632 |